UpHill, a digital health startup, raised a $4.1 million seed round led by Brighteye Ventures and MSM to scale up its product within healthcare institutions worldwide. Just a month ago, the company also received $1.2M European funding to lead a R&D project on clinical pathways implementation.
Founded in 2015 by three medical doctors, the Lisbon-based startup aims to standardize clinical care, support healthcare professionals' productivity during this process, and improve healthcare quality.
“Even within the same hospital, the way each person is treated heavily depends on the medical team by whom each patient is being assisted. This variability impacts patients’ outcomes and organizations' efficiency, making it hard to understand which set of actions led to the best results and what should be optimized,” Eduardo Freire Rodrigues, UpHill CEO and co-founder, explains. “Our solution works as a GPS for healthcare settings, providing real-time, evidence-based, and multidisciplinary guidance on which path should be followed by a particular patient. As a result, clinicians improve compliance with best practices easily, organizations reduce unwarranted waste, and patients’ outcomes become more predictable.”
UpHill has a market presence in Portugal, and ongoing projects in Greece, Norway, the Netherlands and Sweden.
JMDedu is a leading B2B EdTech Media in China that informs and connects business professionals through our reports, events, and information services. Our mission is to drive the advancement of education. Our network spans the education industry in China as well as globally, including entrepreneurs, investors, startups, educators, business decision-makers, and policy decision-makers.
